米国の光線療法市場調査レポート : 2030年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2023年6月

US Light Therapy Market Research Report Forecast to 2030
米国の光線療法市場調査レポート : 2030年までの予測

レポート目次　　お問合せ・ご注文　　価格・納期について

US Light Therapy Market Research Report Forecast to 2030
Market Overview
The growth of the US light therapy market is attributed to the growing preference of patients toward non-invasive procedures, growing concern about mental health and rising demand for various depression therapies, and a rising number of strategic initiatives. However, side effects and risk associated with light therapy and lack of awareness among people is anticipated to hamper the market growth.
Light therapy, often known as phototherapy, is a method of medical care that uses artificial lighting. It is primarily used to treat seasonal affective disorder, a form of seasonal depression. This treatment compensates for the patient’s lack of sun exposure, which is a leading cause of the disease. The light source simulates natural sunlight to assist with rehabilitation. Additionally, many different types of depression and sleep disorders are treated by light therapy. The amount of light utilized in treatment is determined using lux gauges, a unit of measurement.
Light therapy or phototherapy is a treatment type where the patient is exposed to an artificial light source. It mainly affects brain chemicals linked to mood and sleep, and also helps to reset the circadian rhythms, which control the sleep-wake cycle. This therapy is used in the treatment of various disorders, including depression, sleep disorders, jet lag, and Seasonal Affective Disorder (SAD). Factors such as the growing preference of patients toward non-invasive procedures are one of the major factors driving the growth of the light therapy market. Likewise, the rising number of strategic initiatives is further fueling the growth of the market during the review period. However, side effects and risk associated with light therapy is expected to hamper the growth of the light therapy market. Nevertheless, technological advancement in light therapy is anticipated to create lucrative opportunities for the players operating in the light therapy market.
Market Segmentation
Based on the product, the US light therapy market has been segmented into light box, floor & desk lamps, light visors, Handheld Devices for Skin Treatment (HDST), dawn simulators, light therapy bulbs, and others. The floor & desk lamps segment dominated the market in 2021.
Based on light type, the US light therapy market is segmented into white light, red light, blue light, and others. The blue light segment dominated the market in 2021.
On the basis of application, the US light therapy market is segmented into psoriasis, vitiligo, eczema, acne vulgaris, Seasonal Affective Disorder (SAD), sleeping disorders, fat loss, mood disorders, and others.
On the basis of end user, the US light therapy market is segmented into homecare settings, hospitals, dermatology clinics, and others. The hospitals segment dominated the market in 2021, while the dermatology clinics segment is projected to be the faster-growing segment during the forecast period.
Major Players
Koninklijke Philips N.V. (Germany), The Beurer Group (Germany), Biophotas (US), Lucimed SA (Belgium), PhotoMedex (US), and Nature Bright (US), Carex (US), and Zepter International (Switzerland).

目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 11
2 MARKET INTRODUCTION 12
2.1 DEFINITION 12
2.2 SCOPE OF THE STUDY 12
2.3 RESEARCH OBJECTIVE 12
2.4 MARKET STRUCTURE 13
2.5 ASSUMPTIONS & LIMITATIONS 14
3 RESEARCH METHODOLOGY 15
3.1 DATA MINING 15
3.2 SECONDARY RESEARCH 16
3.3 PRIMARY RESEARCH 16
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 17
3.5 FORECASTING TECHNIQUES 18
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 19
3.6.1 BOTTOM-UP APPROACH 19
3.6.2 TOP-DOWN APPROACH 20
3.7 DATA TRIANGULATION 20
3.8 VALIDATION 20
4 MARKET DYNAMICS 21
4.1 OVERVIEW 21
4.2 DRIVERS 22
4.2.1 GROWING PREFERENCE OF PATIENTS TOWARD NON-INVASIVE PROCEDURES 22
4.2.2 GROWING CONCERN ABOUT MENTAL HEALTH AND RISING DEMAND FOR VARIOUS DEPRESSION THERAPIES 22
4.2.3 RISING NUMBER OF STRATEGIC INITIATIVES 22
4.3 RESTRAINTS 23
4.3.1 SIDE EFFECTS AND RISK ASSOCIATED WITH LIGHT THERAPY 23
4.3.2 LACK OF AWARENESS AMONG PEOPLE 24
4.4 OPPORTUNITIES 24
4.4.1 TECHNOLOGICAL ADVANCEMENT IN LIGHT THERAPY 24
5 MARKET FACTOR ANALYSIS 25
5.1 VALUE CHAIN ANALYSIS 25
5.1.1 R&D 25
5.1.2 MANUFACTURING 26
5.1.3 DISTRIBUTION & SALES 26
5.1.4 POST-SALES MONITORING 26
5.2 PORTER’S FIVE FORCES MODEL 27
5.2.1 THREAT OF NEW ENTRANTS 27
5.2.2 BARGAINING POWER OF SUPPLIERS 27
5.2.3 THREAT OF SUBSTITUTES 28
5.2.4 BARGAINING POWER OF BUYERS 28
5.2.5 INTENSITY OF RIVALRY 28
5.3 IMPACT OF COVID-19 ON THE US LIGHT THERAPY MARKET 28
5.3.1 IMPACT ON VALUE CHAIN 28
5.3.2 IMPACT ON SUPPLY CHAIN 28
5.3.3 IMPACT ON MARKET GROWTH 29
5.4 QUALITATIVE DATA ON LIGHT THERAPY FOR FAT-LOSS 29
6 US LIGHT THERAPY MARKET, BY PRODUCT 30
6.1 OVERVIEW 30
7 US LIGHT THERAPY MARKET, BY LIGHT TYPE 32
7.1 OVERVIEW 32
8 US LIGHT THERAPY MARKET, BY APPLICATION 34
8.1 OVERVIEW 34
9 US LIGHT THERAPY MARKET, BY END USER 36
9.1 OVERVIEW 36
10 COMPETITIVE LANDSCAPE 38
10.2 COMPETITIVE BENCHMARKING 39
10.3 MAJOR GROWTH STRATEGY IN US LIGHT THERAPY MARKET 40
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN US LIGHT THERAPY MARKET 41
10.5 KEY DEVELOPMENT ANALYSIS 41
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 42
10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 42
10.6.2 PARTNERSHIP/ COLLABORATION 42
10.6.3 EXPANSION/ AGREEMENT 42
10.7 MAJOR PLAYERS SALES ANALYSIS 43
10.8 MAJOR PLAYERS R&D ANALYSIS 43
11 COMPANY PROFILES 44
11.1 KONINKLIJKE PHILIPS N.V. 44
11.1.1 COMPANY OVERVIEW 44
11.1.2 FINANCIAL OVERVIEW 45
11.1.3 PRODUCTS/SERVICES OFFERED 46
11.1.4 KEY DEVELOPMENTS 46
11.1.5 SWOT ANALYSIS 47
11.1.6 KEY STRATEGIES 47
11.2 NORTHERN LIGHT TECHNOLOGIES 48
11.2.1 COMPANY OVERVIEW 48
11.2.2 FINANCIAL OVERVIEW 48
11.2.3 PRODUCTS/SERVICES OFFERED 48
11.2.4 KEY DEVELOPMENTS 49
11.2.5 KEY STRATEGIES 49
11.3 VERILUX, INC. 50
11.3.1 COMPANY OVERVIEW 50
11.3.2 FINANCIAL OVERVIEW 50
11.3.3 PRODUCTS/SERVICES OFFERED 50
11.3.4 KEY DEVELOPMENTS 51
11.3.5 KEY STRATEGIES 51
11.4 THE BEURER GROUP 52
11.4.1 COMPANY OVERVIEW 52
11.4.2 FINANCIAL OVERVIEW 52
11.4.3 PRODUCTS/SERVICES OFFERED 52
11.4.4 KEY DEVELOPMENTS 52
11.4.5 SWOT ANALYSIS 53
11.4.6 KEY STRATEGIES 53
11.5 THERALIGHT, LLC 54
11.5.1 COMPANY OVERVIEW 54
11.5.2 FINANCIAL OVERVIEW 54
11.5.3 PRODUCTS/SERVICES OFFERED 54
11.5.4 KEY DEVELOPMENTS 54
11.5.5 SWOT ANALYSIS 55
11.5.6 KEY STRATEGIES 55
11.6 CAREX 56
11.6.1 COMPANY OVERVIEW 56
11.6.2 FINANCIAL OVERVIEW 56
11.6.3 PRODUCTS OFFERED 56
11.6.4 KEY DEVELOPMENTS 57
11.6.5 SWOT ANALYSIS 58
11.6.6 KEY STRATEGIES 58
11.7 LUCIMED SA 59
11.7.1 COMPANY OVERVIEW 59
11.7.2 FINANCIAL OVERVIEW 59
11.7.3 PRODUCTS OFFERED 59
11.7.4 KEY DEVELOPMENTS 59
11.7.5 KEY STRATEGIES 60
11.8 ZEPTER INTERNATIONAL 61
11.8.1 COMPANY OVERVIEWS 61
11.8.2 FINANCIAL OVERVIEW 61
11.8.3 PRODUCTS OFFERED 61
11.8.4 KEY DEVELOPMENTS 61
11.8.5 SWOT ANALYSIS 62
11.8.6 KEY STRATEGIES 62
11.9 PHOTOMEDEX 63
11.9.1 COMPANY OVERVIEW 63
11.9.2 FINANCIAL OVERVIEW 63
11.9.3 PRODUCTS OFFERED 63
11.9.4 KEY DEVELOPMENTS 63
11.9.5 KEY STRATEGIES 63
11.10 NATURE BRIGHT 64
11.10.1 COMPANY OVERVIEW 64
11.10.2 FINANCIAL OVERVIEW 64
11.10.3 PRODUCTS OFFERED 64
11.10.4 KEY DEVELOPMENTS 64
11.10.5 KEY STRATEGIES 64
11.11 MEDISANA GMBH 65
11.11.1 COMPANY OVERVIEW 65
11.11.2 FINANCIAL OVERVIEW 65
11.11.3 PRODUCTS OFFERED 65
11.11.4 KEY DEVELOPMENTS 65
11.11.5 KEY STRATEGIES 65
11.12 LUMIE 66
11.12.1 COMPANY OVERVIEW 66
11.12.2 FINANCIAL OVERVIEW 66
11.12.3 PRODUCTS OFFERED 66
11.12.4 KEY DEVELOPMENTS 66
11.12.5 KEY STRATEGIES 66
11.13 BIOPHOTAS 67
11.13.1 COMPANY OVERVIEW 67
11.13.2 FINANCIAL OVERVIEW 67
11.13.3 PRODUCTS OFFERED 67
11.13.4 KEY DEVELOPMENTS 68
11.13.5 KEY STRATEGIES 68
11.14 JOHNSON & JOHNSON SERVICES, INC. 69
11.14.1 COMPANY OVERVIEWS 69
11.14.2 FINANCIAL OVERVIEW 70
11.14.3 PRODUCTS OFFERED 70
11.14.4 KEY DEVELOPMENTS 70
11.14.5 KEY STRATEGIES 71
11.15 NUSHAPE 72
11.15.1 COMPANY OVERVIEW 72
11.15.2 FINANCIAL OVERVIEW 72
11.15.3 PRODUCTS OFFERED 72
11.15.4 KEY DEVELOPMENTS 72
11.15.5 KEY STRATEGIES 72
12 APPENDIX 73
12.1 REFERENCES 73
12.2 RELATED REPORTS 74
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17
TABLE 3 US: LIGHT THERAPY MARKET, BY PRODUCT, 2018–2030 (USD MILLION) 31
TABLE 4 US: LIGHT THERAPY MARKET, BY LIGHT TYPE, 2018–2030 (USD MILLION) 33
TABLE 5 US LIGHT THERAPY MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 35
TABLE 6 US LIGHT THERAPY MARKET, BY END USER, 2018–2030 (USD MILLION) 37
TABLE 7 MAJOR MANUFACTURERS IN US LIGHT THERAPY MARKET 38
TABLE 8 MOST ACTIVE PLAYER IN LIGHT THERAPY MARKET 41
TABLE 9 PRODUCT LAUNCH/ PRODUCT APPROVAL 42
TABLE 10 PARTNERSHIP/ COLLABORATION 42
TABLE 11 EXPANSION/AGREEMENT 42
TABLE 12 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 46
TABLE 13 NORTHERN LIGHT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED 48
TABLE 14 VERILUX, INC.: PRODUCTS/SERVICES OFFERED 50
TABLE 15 THE BEURER GROUP.: PRODUCTS/SERVICES OFFERED 52
TABLE 16 THERALIGHT, LLC.: PRODUCTS/SERVICES OFFERED 54
TABLE 17 THERALIGHT, LLC: KEY DEVELOPMENTS 54
TABLE 18 CAREX: PRODUCTS OFFERED 56
TABLE 19 LUCIMED SA: PRODUCTS OFFERED 59
TABLE 20 ZEPTER INTERNATIONAL: PRODUCTS OFFERED 61
TABLE 21 PHOTOMEDEX: PRODUCTS OFFERED 63
TABLE 22 NATURE BRIGHT: PRODUCTS OFFERED 64
TABLE 23 MEDISANA GMBH: PRODUCTS OFFERED 65
TABLE 24 LUMIE: PRODUCTS OFFERED 66
TABLE 25 BIOPHOTAS: PRODUCTS OFFERED 67
TABLE 26 BIOPHOTAS: KEY DEVELOPMENTS 68
TABLE 27 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 70
TABLE 28 NUSHAPE PRODUCTS OFFERED 72

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 11
FIGURE 2 US LIGHT THERAPY MARKET 13
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 19
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE US LIGHT THERAPY MARKET 21
FIGURE 5 DRIVER IMPACT ANALYSIS 23
FIGURE 6 RESTRAINT IMPACT ANALYSIS 24
FIGURE 7 VALUE CHAIN ANALYSIS: US LIGHT THERAPY MARKET 25
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: US LIGHT THERAPY MARKET 27
FIGURE 9 US LIGHT THERAPY MARKET, BY PRODUCT, 2021 AND 2030 (USD MILLION) 31
FIGURE 10 US LIGHT THERAPY MARKET, BY LIGHT TYPE, 2021 AND 2030 (USD MILLION) 32
FIGURE 11 US LIGHT THERAPY MARKET, BY APPLICATION, 2021 AND 2030 (USD MILLION) 35
FIGURE 12 US LIGHT THERAPY MARKET, BY END USER, 2021 AND 2030 (USD MILLION) 37
FIGURE 13 BENCHMARKING OF MAJOR COMPETITORS 39
FIGURE 14 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN US LIGHT THERAPY MARKET 40
FIGURE 15 US LIGHT THERAPY MARKET: COMPETITIVE LANDSCAPE 41
FIGURE 16 MAJOR PLAYERS SALES, 2021 43
FIGURE 17 MAJOR PLAYERS R&D, 2021 43
FIGURE 18 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT 45
FIGURE 19 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 47
FIGURE 20 THE BEURER GROUP: SWOT ANALYSIS 53
FIGURE 21 THERALIGHT, LLC.: SWOT ANALYSIS 55
FIGURE 22 CAREX: SWOT ANALYSIS 58
FIGURE 23 ZEPTER INTERNATIONAL: SWOT ANALYSIS 62
FIGURE 24 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT 70